The study defines cancer microbiome as the aggregate of microorganisms living in or on the human body along with their genomes that are influencing cancer manifestation and progression. Cancer microbiome sequencing has increasingly become an area of interest for the research community, which has the potential to revolutionize cancer care, largely due to studies that have significantly correlated the microbiome’s involvement in cancer manifestation. This study aims at deciphering the potential of the cancer microbiome sequencing and its larger role in bolstering the current era of precision medicine.

1. Market

2. Industry Analysis 

3. Market Dynamics

4. Competitive Landscape 

5. Offering, $Million, 2020 – 2031

6. Application, $Million, 2020 - 2031 

7. Technology, $Million, 2020 - 2031 

8. End User, $Million, 2020-2031 

9. Region, $Million, 2020-2031